Please login to the form below

Not currently logged in
Email:
Password:

Joint ownership for Indigenus network

Thirteen agencies pool resources to provide global creative services to healthcare clients

The 13 independent agencies in the Indigenus network have formally pooled their resources to provide a global creative service to healthcare clients by becoming a limited liability company (LLC).

By unifying under a joint-ownership structure, the founding partners believe that they can offer clients delivery of inspired creative and strategic thinking.

With a network spanning both major and emerging global markets, Indigenus helps pharmaceutical and healthcare companies in the fields of multichannel global branding, advertising, medical education and medical communications. It has local agency teams that work in partnership with global brand teams.

"Indigenus has always brought together the best entrepreneurial brains in the business," said Rico Viray, founding partner of Indigenus and The CementBloc in New York, US. "Clients know they can get consistently superior thinking from independent creative agencies, and we join forces to allow clients to tap into this kind of service on a global basis."

The 13 agencies are: The CementBloc (US), PAN Advertising (UK), Umbilical (Spain), Strategik & Numerik (France), Serviceplan (Germany), thenewway (Italy), Marketing Latino (Mexico), Sorento Health (India), Graphinn (Turkey), me&lewis (Canada), Lindh & Partners (Sweden), PharMa International (Japan) and Micó Publicidad (Argentina).

The Indigenus Transcreation Center (ITC), based in New York, US, caters for the emerging markets via its culturally sensitive adaptation and translation services to manage cost-efficient rollouts across local markets. It has a 200-country virtual network.

Indigenus was founded in 2004 to provide an alternative to traditional advertising agency conglomerates. In 2011, Indigenus will continue to expand its network and has potential agency partners in Brazil, Australia, China, and Russia.

14th April 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...